As India faces a second wave of COVID-19, PerkinElmer Inc., will donate 1 million PerkinElmer^® COVID-19 Antigen Tests to the Government of India (GoI) to help accelerate testing capabilities across the country.

With the support of the US-India Strategic Partnership Forum (USISPF), PerkinElmer COVID-19 Antigen Test kits will be distributed to government hospitals and testing centers across 10 states of India.

The PerkinElmer COVID-19 Antigen Test is a lateral flow immunoassay ideally suited for point-of-care (POC) and non-clinical settings. The CE marked assay may be used with nasal or nasopharyngeal swab specimens to screen or to aid in the diagnosis of both asymptomatic and symptomatic individuals, and it is capable of delivering a positive or negative result in as little as 15 minutes.

“The second wave of COVID-19 in India has mobilized our teams around the world to help in whichever ways we can,” said Deepak Tripathi, CEO of Tulip Diagnostics, a PerkinElmer company. “We’re working around the clock to assist employees and customers across India through this incredibly challenging time, with the hope that by providing vital goods and services needed to create a seamless testing network, we can help stop the spread of this terrible disease.”